Privia Health Group Inc (PRVA)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) is a financial ratio that measures how long it takes a company to collect payment from its customers after making a sale. However, the data provided for Privia Health Group Inc does not include specific values for DSO, as all entries are indicated as "— days" for various reporting dates from December 31, 2020, to December 31, 2024.
As a result of the lack of specific DSO figures, it is not possible to analyze the trend or make a meaningful interpretation of Privia Health Group Inc's collection efficiency over time. The absence of data restricts the ability to assess the company's effectiveness in managing accounts receivable and could potentially hinder a comprehensive analysis of its liquidity position and operational performance.
To draw meaningful insights into Privia Health Group Inc's DSO and its implications, it would be necessary to obtain accurate and detailed figures for the ratio to evaluate the company's collection policies, working capital management, and overall financial health effectively.
Peer comparison
Dec 31, 2024